Amplify your impact on patient journeys
Our diagnostic assays help you provide more of the answers clinicians and patients need
Our commitment to innovation means a leading-edge menu for labs, and new hope for patients. Every assay we develop is designed with the highest quality in mind. We employ an unprecedented team of over 50 pathologists and disease specialists who evaluate every assay, at every stage of development, beginning with ideation and continuing through the life of the product.1 As a result, More laboratories choose Roche pathology lab assays for quality than any other provider.2
Medical Value: We offer the largest menu of companion diagnostic tests, helping to link patients to 17 different personalized therapies in many different cancers, and counting.3
Quality: A feasibility study, including a minimum of at least 15 assay parameters and 20 tissue types, is completed for every assay we develop—ensuring robust performance in customers’ hands across sample types, instruments, and other real-world variables.
Menu Excellence: The largest menu of ready-to-use assays with over 250 immunohistochemistry (IHC) and in situ hybridization (ISH) assays in key disease areas to enable treatment decisions to be made quickly and confidently.1
Featured products
Click on each slide to explore the Assay Portfolio
Customer testimonial: Piedmont Augusta Hospital - Breast cancer testing
Related health topics
- F. Hoffmann-La Roche Ltd. Number of staff pathologists [cited 2024 April 18]. Data on file.
- F. Hoffmann-La Roche Ltd. Maia Strategy Group; Roche Tissue Diagnostics Advanced Staining II [Survey, cited 2022 January]. Data on file.
- F. Hoffmann-La Roche Ltd. 2023 Assays, reagents, and strips competitor information [cited 2024 October 10]. Data on file.